Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
GlaxoSmithKline (GSK)
NYSE:GSK
GlaxoSmithKline (GSK) Stock Price & Analysis
4,539 Followers
GSK Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$32.37 - $43.84
Previous Close$43.45
Volume3.10M
Average Volume (3M)3.36M
Market Cap
$88.77B
Enterprise Value$104.20B
Total Cash (Recent Filing)£5.18B
Total Debt (Recent Filing)£18.02B
Price to Earnings (P/E)15.6
Beta0.31
Next Earnings
Jul 31, 2024EPS Estimate
$0.96Next Dividend Ex-Date
May 16, 2024Dividend Yield3.3%
Share Statistics
EPS (TTM)2.78
Shares Outstanding2,058,516,719
10 Day Avg. Volume3,530,898
30 Day Avg. Volume3,362,068
Standard Deviation0.06
R-Squared0.43
Alpha0.00124
Financial Highlights & Ratios
Price to Book (P/B)-8.67
Price to Sales (P/S)2.95
Price to Cash Flow (P/CF)6.60
P/FCF Ratio8.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$46.00Price Target Upside4.19% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
GlaxoSmithKline News
PremiumCompany Announcements
GSK’s 24th AGM Sees High Approval Rates
PremiumCompany Announcements
GSK Announces Key Board Committee Changes
PremiumCompany Announcements
GSK Executive Sells Shares on London ExchangeOwnership Overview
0.00%
Insiders
4.56% Mutual Funds
2.37% Other Institutional Investors
93.07% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
GSK FAQ
What was GlaxoSmithKline’s price range in the past 12 months?
GlaxoSmithKline lowest stock price was $32.37 and its highest was $43.84 in the past 12 months.
What is GlaxoSmithKline’s market cap?
Currently, no data Available
When is GlaxoSmithKline’s upcoming earnings report date?
GlaxoSmithKline’s upcoming earnings report date is Jul 31, 2024 which is in 84 days.
How were GlaxoSmithKline’s earnings last quarter?
GlaxoSmithKline released its earnings results on May 01, 2024. The company reported $1.077 earnings per share for the quarter, beating the consensus estimate of $0.922 by $0.155.
Is GlaxoSmithKline overvalued?
According to Wall Street analysts GlaxoSmithKline’s price is currently Undervalued.
Does GlaxoSmithKline pay dividends?
GlaxoSmithKline pays a Quarterly dividend of $0.37 which represents an annual dividend yield of 3.3%. See more information on GlaxoSmithKline dividends here
What is GlaxoSmithKline’s EPS estimate?
GlaxoSmithKline’s EPS estimate is $0.96.
How many shares outstanding does GlaxoSmithKline have?
GlaxoSmithKline has 2,072,462,000 shares outstanding.
What happened to GlaxoSmithKline’s price movement after its last earnings report?
GlaxoSmithKline reported an EPS of $1.077 in its last earnings report, beating expectations of $0.922. Following the earnings report the stock price went up 2.727%.
Which hedge fund is a major shareholder of GlaxoSmithKline?
Among the largest hedge funds holding GlaxoSmithKline’s share is Dodge & Cox. It holds GlaxoSmithKline’s shares valued at 3B.
---
GlaxoSmithKline Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$46.00 (4.19% Upside)
$46.00 (4.19% Upside)
Blogger Sentiment
Bullish
GSK Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 2.9M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.8%
Last 30 Days ▼ 3.0%
Last 30 Days ▼ 3.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
22.19%
12-Months-Change
Fundamentals
Return on Equity
35.18%
Trailing 12-Months
Asset Growth
2.02%
Trailing 12-Months
Company Description
GlaxoSmithKline
Founded in 1715 and headquartered in Brentford, U.K., GlaxoSmithKline Plc is a global healthcare company which develops and manufactures pharmaceutical medicines in therapeutic areas, vaccines and consumer healthcare products in wellness, oral health, nutrition, and skin health categories.
---
GSK Company Deck
---
GSK Earnings Call
Q1 2024
0:00 / 0:00
---
GSK Stock 12 Month Forecast
Average Price Target
$46.00
▲(4.19% Upside)
Technical Analysis
Best Analysts Covering GSK
1 Year
1 Year Success Rate
3/10 ratings generated profit
1 Year Average Return
-7.22%
reiterated a sell rating 22 days ago
Copying Graham Parry's trades and holding each position for 1 Year would result in 30.00% of your transactions generating a profit, with an average return of -7.22% per trade.
---